Annual Revenue Growth (Last Twelve Months): Insight Molecular Diagnostics (IMDX)

Brandmark of Insight Molecular Diagnostics, Inc. (IMDX)

The development of tests for early cancer detection via liquid biopsy is accelerating innovation at Insight Molecular Diagnostics (IMDX). A staff of bioinformaticians operates under strict FDA regulations to ensure research accuracy. The percentage change in sales over the last 12 months compared to the previous 12 months demonstrates revenue dynamics, where the value -61.10 captures the metric level. Biomarker patents and CLIA certification ensure a high barrier to entry.

Sales Growth YoY (TTM): Insight Molecular (IMDX) for 11/23/2025 - 11/16/2026

Insight Molecular Diagnostics Inc - analytical breakdowns and key metrics (IMDX)

- company stock exchange capitalization indicators:
Fundamental company valuation:Insight Molecular Diagnostics Inc
Brand item of imdxinc.com

The success of Insight Molecular Diagnostics (IMDX) depends on the integration of high-precision oncology tests into public healthcare systems. Relative year-over-year (LTM) revenue dynamics measure the percentage change in total income over the trailing twelve months compared to the same period last year. Growth in this metric confirms the scaling of the molecular diagnostics platform. A slowdown in growth rates amid high capitalization signals a risk of asset overvaluation. A stable upward trend confirms the fundamental resilience of the business.

Competitors of Insight Molecular Diagnostics (IMDX)

Agilent Corp (A) - Trailing Twelve Months Revenue Growth|DGX - Sales Growth YoY (Last Twelve Months)|ILMN: Sales Growth YoY (Last Twelve Months)|EXAS: Sales Growth YoY (TTM)|RVTY (Revvity) - Sales Growth YoY (Last Twelve Months)|BIO (Bio-Rad Laboratories, Inc.) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Anbio Biotechnology NNNN|Revenue Growth YoY (Last 12 Months) SHC (Sotera Health Company)|Sales Growth YoY (Last Twelve Months) QDEL (quidel.com)|Sales Growth YoY (TTM) OPK (opko.com)|Revenue Dynamics YoY (Last Twelve Months) CDNA|MRVI: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) FLGT (Fulgent Corp)|LAB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth cytekbio.com (CTKB)|OSUR (OraSure Corp) - Sales Growth YoY (TTM)|Exagen (XGN) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) MDxHealth, Inc. (MDXH)|Lucid Diagnostics, Inc - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (Last Twelve Months) Prenetics PRE|Revenue Change YoY (Last 12 Months) TRIB (Trinity Biotech Corp)|PRPH - Sales Growth YoY (Last Twelve Months)|Ainos (AIMD) - Revenue Growth YoY (Last 12 Months)|CoDx (CODX) - Sales Growth YoY (Last Twelve Months)|HSCS (Heart Test Labs) - Sales Growth YoY (Last Twelve Months)|BMRA (Biomerica, Inc.) - Sales Growth YoY (TTM)|CDIO (Cardio Diagnostics) - Revenue Change YoY (Last 12 Months)|Sales Growth YoY (Last Twelve Months) Onconetix Corp (ONCO)|VRAX (Virax Biolabs Group Limited) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) BJDX (Bluejay Diagnostics Corp)|Aspira Women's Health - Sales Growth YoY (Last Twelve Months)|AXDX - Sales Growth YoY (Last Twelve Months)|Revenue Growth Rate YoY (Last Twelve Months) Centogene NV (CNTG)|ENZ (Enzo Biochem) - Revenue Growth YoY (Last 12 Months)|fresh2.co (FRES) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) Genetic Technologies Limited|Trailing Twelve Months Revenue Growth 23andMe Inc. ME|Sales Growth YoY (Last Twelve Months) Psychemedics (PMD)